Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Gus
    Member
    • Dec 2009
    • 29

    State of the field? mapping transcripts to the genome for improving annotation

    I posted this over at Biostars but it has not gotten much response so I am posting it here too.

    I work on Mosquitoes which have notoriously bad annotations in their UTRs. I have a bunch of RNA-seq data that I want to use to help me better define the UTRs in the genes being expressed in my tissues. This is important because I want to study the putative promoter regions. As it is now, MANY regions 5' to the annotated start of the transcript are either UTR or intron due to the gene model missing the first exon (an all UTR exon).

    My plan is to use a few de novo transcript assembly programs to come up with putative cDNA transcripts, then to map these to the genomes to 'annotate' the gene structures and then merge those into the official gtf annotations. For my specific use, the most important things are the border regions (start/stop of transcription), but I plan to publish the amended annotations in an effort to make the work more reproducible. And if they are going to be published, I would like the "guts" to be as accurate with regard to splicing as is reasonably possible.

    I was planning to use exonerate, but in the last few weeks, I have read about other options such as using GMAP or simply using BLAT.

    Is there a feeling of which mapper/method produces the best results at this time?
    In science, "fact" can only mean "confirmed to such a degree that it would be perverse to withhold provisional assent." I suppose that apples might start to rise tomorrow, but the possibility does not merit equal time in physics classrooms.
    --Stephen Jay Gould

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...